Maternal Depressive Symptoms Linked to Slower Fetal Growth
By Elana Gotkine HealthDay Reporter
MONDAY, Dec. 4, 2023 -- Maternal depressive symptoms are associated with slower fetal growth rate in the critical rapid growth stage (CRGS) before delivery, according to a study published online Dec. 4 in JAMA Network Open.
Lu Zhang, M.P.H., from Sichuan University in Chengdu, China, and colleagues conducted a prospective multicenter birth cohort study to examine the association between maternal depressive symptoms and fetal growth during the CRGS before delivery. A total of 2,676 mother-offspring dyads were included.
The researchers observed a significant correlation between a higher score of depressive symptoms in mothers and a slower rate of fetal growth across femur length, abdominal circumference, and estimated fetal weight (β = −0.40, −1.97, and −50.11, respectively) after adjustment for confounders. In female fetuses or those with better family socioeconomic conditions, these associations were found to be stronger.
"These findings underscore the importance of early detection and management of maternal depressive symptoms during pregnancy, particularly among women with higher socioeconomic status or female fetuses," the authors write.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2023-12-05 00:36
Read more
- Uplizna (inebilizumab-cdon) is Now the First and Only FDA-Approved Treatment for IgG4-Related Disease
- Dual-Use of Cigarettes, E-Cigarettes Tied to Same Toxicant Exposure as Cigarettes Alone
- Acute Care for Cannabis Use Increases Risk for Subsequent New Dementia Diagnosis
- CDC Urges Extra Measles Shot for Some U.S. Travelers Amid Outbreak
- Tolebrutinib Phase 3 Data Published in NEJM Demonstrate Benefit on Disability Progression in Multiple Sclerosis
- DDW: Certain Proteins Predict Metabolic Dysfunction-Associated Steatotic Liver Disease
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions